Abstract
Safety and Efficacy of Ozanimod in Patients with Early Relapsing Multiple Sclerosis: 1-year Analysis of the ENLIGHTEN Study (P10-6.014)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have